Glades Drugs Recalls Vitamin D3 Supplement Due to Excessive Potency
Glades Drugs Inc. is recalling Vitamin D3 supplement capsules because they contain an extremely high level of vitamin D3.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The source text explicitly identifies the agency classification as Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
Glades Drugs Inc. is recalling Vitamin Supplement (Vial) D3 capsules, which contain cholecalciferol (vitamin D3), lipoic acid, ubiquinol, methylcobalamin, pyridoxine, methionine, inositol, and choline bitartrate USP. The recall involves 60, 120, or 180 count vials. The total quantity affected is 7,800 capsules.
The FDA has classified this as a Class I recall because the product is a superpotent drug, meaning it contains an extremely high level of vitamin D3. This excessive potency poses a significant risk of adverse health consequences to consumers.
The affected products were distributed in New York and Georgia. Consumers should stop using the recalled capsules and check their lot codes against the list provided by the FDA, which includes codes such as AICACABF@3 and AICECABF@2, with an expiration date of 02/20/2016.
The recalled product
- Product
- Vitamin Supplement (Vial) D3, (cholecalciferol (vit D3)/lipoic acid/ubiquinol/ methylcobalamin/pyridoxine/methionine/inositol/choline bitartrate USP) capsules, 60, 120 or 180 count vials, Glades Drugs, 109 S. Lake Ave., Pahokee, FL 33476.
- Manufacturer
- Glades Drugs Inc.
- Category
- Drug — Vitamin Supplement
- Affected units
- 7,800
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- AICACABF@3
- AICECABF@2
- AJBFCABF@4
- ABCCABF@4
- AICACABF@5
- AICECABF@3
- AJBHCABF@2
- ABCCABF@5
- AICBCABF@1
- AICECABF@4
- AJCBCABF@1
- ABGCABF@4
- AICBCABF@2
- AICECABF@5
- JCBCABF@2
- BACDCABF@5
- AICBCABF@3
- AICICABF@3
- BAAGCABF@2
- BADACABF@3
Distribution
Related recalls
Other drug recalls
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02